Einhorn Andrew J. 4
4 · Osmotica Pharmaceuticals plc · Filed Nov 8, 2021
Insider Transaction Report
Form 4
Einhorn Andrew J.
Chief Financial Officer
Transactions
- Award
Share Option (Right to Buy)
2021-11-04+249,814→ 249,814 totalExercise: $1.80Exp: 2031-11-04→ Ordinary Shares (249,814 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the ordinary shares underlying the award on the first anniversary of the grant and as to the remaining 75% of the shares in thirty-six (36) equal monthly installments thereafter.